Journal profile

Current reviews in clinical and experimental pharmacology

Publisher: Bentham Science Publishers
ISSN2772-4336 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.90
Citation rate 2.51 140 total citations
h5-index 17 h5 depth signal
Cited share 57.9% 33 of 57
Total citations 140 Citation footprint
Metric signal 2.14 External metric anchor
Self-citation 0.0% 0 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

India 53
Iran 33
United States 29
China 14
Italy 10

Citing Fields of Research

Pharmacology & Toxicology 25
Cardiology 22
Neurodegenerative Disorders 17
Anesthetic & Pain Medicine 15
Phytochemicals 14

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 216 Articles tracked across the journal lifetime
Indexed publication set 57 33 cited publications
Last 12 months 37 4.1 publications/month
Open access share 0.0% 0 OA publications in the last year
Leading citing country India 53 citing publications
Leading citing field Pharmacology & Toxicology 25 citing publications
Latest tracked publication 7 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v16n1, Feb. 2021-
PubMed
v16n1, Feb. 2021-

Research Focus & Classification

Indexed Subjects

Neurodegenerative Disorders Cardiology Pharmacology & Toxicology Phytochemicals Diabetes Neurosciences Anesthetic & Pain Medicine

Broad Categories

Pharmacology Phytochemicals Neurodegenerative Disorders Digestive Disorders Inflammatory Bowel Diseases & Infections Neurosciences Anesthetic & Pain Medicine Cancer Drugs

MeSH Descriptors

Pharmacological Phenomena Pharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
David Nedeljkovic, Nikola Todorovic, Dejan Javorac et al.
Introduction: Molecular hydrogen (H2) has gained attention as a therapeutic agent due to its antioxidant and anti-inflammatory properties. However, human Pharmacokinetic (PK) data remain limited, particularly for Hydrogen-Rich Water (HRW...
02
Shalini Dwivedi, Jeanine Giarolla Vargas, Samridhi Lal
Introduction: Over the last decade, the regulation of cannabinoids and cannabis-based medicinal products has undergone significant transformation, determined by growing evidence of their therapeutic value and increasing concerns about sa...
03
Marianne Levon Shahsuvaryan
Varying degrees of visual impairment up to complete blindness are widespread and represent a public health problem with a highly demarсated escalation. Currently, the leading causes of blindness are Diabetic Retinopathy (DR), Age-Related...
04
Mohammad Mehdi Abbasi, Shiva Pasha, Farbod Khosravi et al.
Introduction/Objective: Sleep disruption is common among patients with malignancy and may worsen quality of life, treatment tolerance, and symptom burden. Melatonin is a circadianregulating hormone with a favorable safety profile and pot...
10
Solmaz Maleki Dizaj, Mohammad Yousef Memar, Simin Sharifi et al.
Osteomyelitis is difficult to treat due to biofilm persistence, limited antibiotic penetration, and increasing resistance. Curcumin, a pleiotropic polyphenol from Curcuma longa, shows convergent activity relevant to bone infection: (i) a...

Bibliographical & Catalog Notes

Some volumes have thematic issues.

Also issued in print.